Revenue
attach_money38M USD
-
IBRXImmunityBio, Inc.$ --
ImmunityBio, Inc.
IBRX
$ -
-
Review earnings summary, surprise history, and upcoming forecasts.
analyticsEarnings Summary
FY2025 Q4Updated: 12/31/2025
Operating Income
trending_up-65M USD
-
Net Income
verified-62M USD
-
EPS
paid-0.06$
-
Revenue
$38.3M
BEAT
$16M
$16.5M
$23.1M
$26.4M
$31.9M
$32.1M
$38.4M
$38.3M
$109.4M
$113.3M
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-
Net Income
$-61.9M
BEAT
$-126.7M
$-129.6M
$-106.9M
$-92.6M
$-106M
$-67.3M
$-75.7M
$-61.9M
$-415.3M
$-351.4M
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-
Surprise History
ActualEstimate
FY2025MISS